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To the Editor: Chikungunya virus (CHIKV), an 
arthropod-borne virus (arbovirus) of the family Togaviridae, 
genus Alphavirus, is transmitted by mosquitoes of the 
Aedes genus, especially Ae. aegypti and Ae. albopictus (1). 
The main clinical manifestations of CHIKV infections are 
sudden high fever, headache, back pain, myalgia, arthralgia 
affecting mainly the extremities, and rash.
CHIKV emerged in the Pacific region in New 
Caledonia in March 2011. Additional outbreaks occurred 
in Papua New Guinea in June 2012; Yap State (Federated 
States of Micronesia) in August 2013; Tonga in April 2014; 
and American Samoa, Samoa, and Tokelau in July 2014 
(2). Phylogenetic analysis of CHIKV strains showed the 
existence of 3 lineages: West African, Asian, and East/
Central/South African (1).
French Polynesia is a French territory in the South 
Pacific, with 270,000 inhabitants living on 5 archipelagoes. 
Arboviruses are a common cause of outbreaks in French 
Polynesia: the last dengue virus (DENV) outbreaks caused 
by DENV-1 and DENV-3 occurred in 2013 (3), and DENV-
1 still circulates. French Polynesia also experienced the 
largest Zika virus (ZIKV) outbreak ever reported during 
October 2013–April 2014 (4). In May 2014, CHIKV 
infection was detected for the first time in French Polynesia 
in a traveler returning from Guadeloupe, (5) where a 
chikungunya outbreak was ongoing (6).
In late September 2014, an increasing number of 
patients with fever and rash who tested negative for 
DENV and ZIKV by real-time reverse transcription 
PCR (RT-PCR) were recorded by the French Polynesia 
Department of Health on the south coast of Tahiti, French 
Polynesia’s main island. Serum samples collected from 
19 of these patients were tested for CHIKV by RT-PCR 
using previously reported primers and a probe (7). Seven 
of the 19 (37%) were positive; all 7 were autochthonous. 
The first specimen that tested positive for CHIKV had been 
collected from a patient on September 25, and by October 
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25, a total of 318 patients were confirmed by RT-PCR to 
be infected by CHIKV. Nearly all districts of Tahiti were 
affected, and cases were reported on 4 of French Polynesia’s 
5 archipelagoes.
Partial sequencing of the CHIKV E1 gene of a strain 
isolated from a patient and collected on September 29 (strain 
PF14-290914-16, GenBank accession no. KM985619) 
was performed as previously reported (8). Phylogenetic 
analysis showed that French Polynesia’s CHIKV strain 
belongs to the Asian lineage and is more closely related 
to a strain collected in the British Virgin Islands in 2014 
(VG14/99659) and to the French Polynesian strain 
imported from Guadeloupe in May 2014 (PF14-270514-
51impGP), with 99.9% homology, than to the strains 
that recently circulated in Yap State (FM13/3807), Tonga 
(TO14-080414-3007 and TO14-080414-3042), and New 
Caledonia (NC11-568) (Figure).
No cases of CHIKV infection were reported in 
French Polynesia within the 4 months after the imported 
case detected on May 25, 2014. Because of the active, 
ongoing circulation of CHIKV in the Pacific, introduction 
of this virus in French Polynesia was expected from other 
Pacific islands, especially from New Caledonia, because of 
extensive travel between the 2 French territories.
The fact that the CHIKV strain circulating in French 
Polynesia is closely related to the strains currently circulating 
in the Caribbean suggests that the French Polynesia 
outbreak is a result of the introduction of CHIKV from the 
Caribbean rather than from another Pacific island. The delay 
between the current outbreak and the first infected patient 
detected in 2014 also suggests a new introduction rather 
than a circulation of the strain introduced in May. However, 
an undetected low-level circulation of CHIKV during the 
cooler and drier low transmission season, simultaneously 
with DENV-1 circulation, cannot be excluded.
The introduction of arboviruses into French Polynesia 
from other French overseas territories rather than from 
other Pacific islands was previously reported for DENV. In 
2013, DENV-3 reappeared in French Polynesia 3 months 
after the Solomon Islands had declared a DENV-3 outbreak. 
However, epidemiologic and phylogenetic investigations 
revealed that the DENV-3 strain that caused the outbreak in 
French Polynesia had been introduced by a traveler returning 
from French Guiana and belonged to a different genotype 
than the one that was circulating in the Solomon Islands (3).
Several conditions are favorable to a large chikungunya 
outbreak in French Polynesia. First, because CHIKV has 
never been previously reported in French Polynesia, the 
entire population is thought to be immunologically naive for 
CHIKV infection. Second, 2 potential vectors for CHIKV 
are present in French Polynesia: Ae. aegypti (1) and Ae. 
polynesiensis mosquitoes (9). Third, in French Polynesia 
the hot and rainy season that lasts from October through 
March is conducive to the proliferation of mosquitoes. 
We have the experience of the French Polynesian ZIKV 
outbreak that started with the same favorable conditions 
in October 2013 and was responsible for 28,000 estimated 
symptomatic cases from October 2013 through April 2014 
(10). This new outbreak corroborates the recent observation 
that the expansion of arboviruses in the Pacific is ongoing 
and inevitable (2).
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Figure. Phylogenetic analysis of chikungunya virus strain isolated 
in French Polynesia on September 29, 2014. The evolutionary 
history was inferred by using the maximum-likelihood method 
based on the Kimura 2-parameter model. The percentage of 
trees in which the associated taxa clustered together is shown for 
values >90 next to the branches (1,000 replicates). Evolutionary 
analyses were conducted in MEGA6 (http://www.megasoftware.
net/mega.php). Each strain is labeled by country (iso country 
code, 2-letter) and date of origin/strain name/GenBank accession 
number. The chikungunya virus strain isolated in French Polynesia 
on September 2014 is marked with a black circle. Scale bar 
indicates nucleotide substitutions per site.
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To the Editor: The World Health Organization rec-
ommends that persons who return from pilgrimages to 
the Middle East with acute severe respiratory infections 
be tested to determine the cause of infection; the aim is 
to identify infections with the Middle East respiratory syn-
drome coronavirus (MERS-CoV), which have been occur-
ring in Saudi Arabia since 2012. Each year, >2.5 million 
persons from >180 countries, including 240,000 pilgrims 
from Europe, participate in Hajj, the Muslim pilgrimage to 
Mecca, Saudi Arabia. The gathering of mass numbers of 
persons during the Hajj increases the risk for the spread 
of respiratory infections among participants, and this risk 
has raised global concern that travelers returning from this 
pilgrimage could contribute to the international spread of 
MERS-CoV. During the 2012 and 2013 Hajj and Umrah 
(a minor pilgrimage) pilgrimages, no MERS cases in pil-
grims were reported (1,2). However, in 2014, cases of 
MERS-CoV infection were confirmed in 2 returning pil-
grims in the Netherlands (3). The International Health 
Regulations Emergency Committee advised all countries to 
improve awareness about MERS-CoV among pilgrims and 
to conduct surveillance for MERS-CoV among pilgrims 
during and after Hajj (4).
According to data from the International Air Trans-
port Association, Austria received an estimated 68,000 air 
travelers from Saudi Arabia, Jordan, Qatar, and the United 
Arab Emirates during June–November 2012 (a period en-
compassing 1 month before Ramadan and 1 month after 
the Hajj) (5); of these travelers, 1,000 were pilgrims per-
forming the Hajj. Relatively constant travel volumes to 
Austria on commercial flights out of these countries during 
2010–July 2014 have been confirmed by an analysis of air 
traffic statistics for Austria (A. Herndler, M. Rudolf, pers. 
comm.). We report on the investigation of illness among 
Austrian residents just after their return home from the 
2014 Hajj pilgrimage, which ended in early October.
As of October 27, 2014, a total of 7 Hajj pilgrims from 
Austria had sought medical care in different Austrian hos-
pitals/medical centers just after returning from Saudi Ara-
bia. The patients had fever and/or respiratory symptoms. 
A summary of the patients’ characteristics is presented in 
the Table. Of the 7 patients, 4 had cough, 1 had dyspnea, 
and 4 had fever. Patients 1, 2, and 7 had an acute febrile ill-
ness and clinical and/or radiologic evidence of pulmonary 
parenchymal disease. Patient 1 had sought medical care in 
Saudi Arabia, and patient 2 had been hospitalized for 10 
days in Saudi Arabia.
For the diagnosis of viral infection, a serum sample and 
a sputum, throat swab, or bronchoalveolar lavage sample 
were collected and sent to the Department of Virology, Med-
ical University of Vienna, Austria, for analysis. All samples 
were tested for MERS-CoV by using reverse transcription 
PCR targeting regions upstream of the envelope gene (6). 
Respiratory and serum samples from all 7 patients were 
negative for MERS-CoV. The respiratory samples were also 
tested for influenza A and B viruses and for rhinoviruses, as 
previously described (7–9). Of the 7 patients, 3 were positive 
for influenza B virus, 2 for influenza A(H3N2) virus, and 
2 for rhinoviruses (Table). Subsequent phylogenetic analy-
sis showed that the influenza A(H3N2) strains belonged to 
the A/Hong Kong/146/2013-like viruses and the influenza B 
strains belonged to the B/Phuket/3073/2013-like viruses of 
the Yamagata lineage, both of which are  subtype H3N2 and 
B strains included in the 2014–15 seasonal influenza vaccine 
for the Northern Hemisphere.
Our results showed that MERS-CoV was not de-
tected in any of these patients, and our findings support 
those from reports investigating illness among 2013 Hajj 
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